Scientists from the IUF – Leibniz Research Institute for Environmental Medicine in Düsseldorf recently published a study on “Reassessment of marker genes in human induced pluripotent stem cells for enhanced quality control” in Nature Communications. The work was conducted together with colleagues from the Max Delbrück Center for Molecular Medicine in Berlin and the University Hospital in Düsseldorf.
(Düsseldorf, 11-NOV-2024) – Human induced pluripotent stem cells (iPSCs) have a great potential for scientific and medical applications. They are used in research laboratories to model human diseases, helping to uncover underlying mechanisms and developing new therapies. Additionally, they are being tested in clinical trials as a solution for regenerative therapies targeting diseases like Parkinson’s, with the goal of restoring function and improving patient outcomes. iPSCs can be obtained from somatic cells, such as those from skin or blood of adult donors, by reprogramming these cells with the help of pluripotency factors, transforming them into cells with embryonic stem cell-like properties. These iPSCs can replicate indefinitely and develop into different tissues making them valuable for research and potentially for personalized regenerative medicine. At the same time, they help to reduce the number of laboratory animals in research.
While quality controls for iPSCs are essential, they are not yet fully standardized. These quality controls include the assessment of morphology, nuclear and mitochondrial genome integrity, and pluripotency, i.e., their capability to differentiate into the three primary germ layers endoderm, ectoderm, and mesoderm. Thus, there is a pressing need for testing methods that are easy, fast, and cost-effective. In former studies the lab of Dr. Andrea Rossi at the IUF – Leibniz Research Institute for Environmental Medicine already looked into mitochondrial genome integrity. A study recently published in Nature Communications by Dobner et al. focuses on pluripotency. The authors used long-read nanopore transcriptome sequencing to discover 172 genes linked to cell states not covered by current guidelines. They validated 12 genes by qPCR (quantitative polymerase chain reaction) as unique markers for specific cell fates: undifferentiated pluripotent iPSCs (CNMD, NANOG, SPP1), endoderm (CER1, EOMES, GATA6), mesoderm (APLNR, HAND1, HOXB7), and ectoderm (HES5, PAMR1, PAX6). Based on these selected genes, they developed a machine learning-based scoring system, “hiPSCore”, which was trained on 15 iPSC lines and validated on additional 10 iPSC lines. The hiPSCore accurately classifies pluripotent and differentiated cells and predicts their potential to become specialized 2D cells and 3D organoids.
“We always strive to improve the methods which we are using”, explains Dr. Andrea Rossi, group leader at the IUF, the approach of the study. “We plan to further develop quality controls for standardized use of iPSCs within the next years.” Dr. Jochen Dobner, first author of the study adds: “Machine learning is an attractive tool to streamline processes. Our developed hiPSCore improves iPSC testing by reducing time, subjectivity, and resource use, thus enhancing iPSC quality for scientific and medical applications.”
486 words, 3356 characters
Publication
Dobner J, Diecke S, Krutmann J, Prigione A, Rossi A: Reassessment of marker genes in human induced pluripotent stem cells for enhanced quality control. Nat Commun 15(1): 8547, 2024. Link: https://doi.org/10.1038/s41467-024-52922-1
Funding
The IUF is funded by the federal and state governments, the Ministry of Culture and Science of North Rhine-Westphalia (MKW), and the Federal Ministry of Education and Research (BMBF). We are grateful for the support from the Deutsche Forschungsgemeinschaft (DFG) (RO5380/1-1, PR1527/6-1) and the AFM-Téléthon (AR-25179).
About the IUF
The central research mission of the IUF is the targeted and personalized prevention of environmentally induced aging and associated diseases. To this end, the IUF is investigating the role of environmental factors in diseases, the underlying mechanisms, how they interact, who is particularly affected and how we can counteract the negative effects of environmental factors in detail. The work focuses on the effects of solar radiation, air pollution, selected chemicals and the interaction with climate factors – on the lung, the skin, the central nervous system and the immune system.
More information: https://iuf-duesseldorf.de/en.
The IUF is part of the Leibniz Association: https://www.leibniz-gemeinschaft.de/en.
Contact
Christiane Klasen, Personal Assistant to the institute’s Director
IUF – Leibniz Research Institute for Environmental Medicine
Auf’m Hennekamp 50
40225 Düsseldorf
Germany
Email: info@IUF-Duesseldorf.de
Phone: +49 (0)211 3389 216